IMB Dx, Inc. (KOSDAQ:461030)
6,490.00
-360.00 (-5.26%)
Mar 9, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 90.98 billion as of March 9, 2026. Its market cap has decreased by -47.49% in one year.
Market Cap
90.98B
Enterprise Value
68.13B
Revenue
4.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,490.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 90.98B, a decrease of -81.94%. That is a compound annual growth rate of -58.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 90.98B | -34.38% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amicogen | 94.41B |
| GeneOne Life Science | 92.36B |
| Oncocross | 85.15B |
| CG Invites | 111.96B |
| ORIENT BIO | 68.89B |
| MedPacto | 174.46B |
| ENCell | 177.52B |
| Macrogen | 185.06B |